FDA Drafts Rules for Proving Generic Estradiol Works Down There
Published Date: 12/8/2025
Notice
Summary
The FDA just dropped new draft guidance for companies making estradiol vaginal inserts and tablets. This guidance helps drug makers design studies to prove their products work the same as already approved ones, speeding up approval. Industry folks should send their feedback by February 6, 2026, so the FDA can finalize the rules—saving time and money in the long run!
Analyzed Economic Effects
4 provisions identified: 3 benefits, 0 costs, 1 mixed.
Draft BE Guidance for Estradiol Generics
If you make generic estradiol vaginal products, the FDA released draft product-specific guidances that give recommendations on the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs) for estradiol vaginal inserts and estradiol vaginal tablets. The guidance names IMVEXXY (NDA 208564, approved May 2018) as the reference listed drug (RLD) for vaginal inserts and VAGIFEM (NDA 020908, approved March 1999) as the RLD for vaginal tablets.
Stakeholder Comment Deadline
Stakeholders, including drug makers, must submit electronic or written comments on the draft guidances by February 6, 2026 for FDA to consider them before it begins work on final versions. Comments go to docket FDA-2007-D-0369 via Regulations.gov or written/paper submission to FDA's Dockets Management Staff.
Paperwork Collections and OMB Approvals
The draft guidances contain no new collections of information but refer to previously approved FDA collections under OMB control numbers 0910-0014 (21 CFR part 312 for investigational new drugs) and 0910-0001 (21 CFR part 314 and part 320 for applications and bioequivalence requirements).
FDA Will Consider Cost Comments
As FDA develops any final guidance, it will consider comments on costs or cost savings the guidance may generate, including comments relevant to Executive Order 14192. Stakeholders may submit such comments by February 6, 2026.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in